Regulations.gov document
Use of a Type V Drug Master File for Model Master File Submissions To Support Abbreviated…
Notice · FDA-2024-N-5975 · posted Jan 17, 2025
Key facts
| Document ID | FDA-2024-N-5975-0001 |
|---|---|
| Title | Use of a Type V Drug Master File for Model Master File Submissions To Support Abbreviated New Drug Applications; Establishment of a Public Docket; Request for Comments |
| Document type | Notice |
| Subtype | Request for Comments |
| Agency | FDA |
| Docket | FDA-2024-N-5975 |
| Posted | Jan 17, 2025 |
| Federal Register citation | 90 FR 5892 |
| FR document number | 2025-01182 |
| Comment period opens | Jan 17, 2025 |
| Comments due | Apr 18, 2025 |
| Effective date | Jan 17, 2025 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: